(Q51681852)

9 April 2018

title

Statisticians and pharmacokineticists: what they can still learn from each other. (English)

1 reference

9 April 2018

author name string

S Senn

series ordinal

1

1 reference

9 April 2018

language of work or name

English

0 references

publication date

7 July 2010

1 reference

9 April 2018

number of pages

7

1 reference

Clinical Pharmacology & Therapeutics

inferred from page(s)

published in

1 reference

9 April 2018

volume

88

1 reference

9 April 2018

issue

3

1 reference

9 April 2018

page(s)

328-334

1 reference

9 April 2018

The intellectual health of clinical drug evaluation

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

The Future of Data Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

On model prespecification in confirmatory randomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

The impact of heterogeneity on the comparison of survival times.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

A critique of recent research on the two-treatment crossover design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

A simulation study comparing designs for dose ranging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

An Argument for Divine Providence, Taken from the Constant Regularity Observ'd in the Births of Both Sexes. By Dr. John Arbuthnott, Physitian in Ordinary to Her Majesty, and Fellow of the College of Physitians and the Royal Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Power and sample size when multiple endpoints are considered

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Designs for dose-escalation trials with quantitative responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Commentary on 'Designs for dose-escalation trials with quantitative responses'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Statistical issues in bioequivalence [correction of bioequivalance].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Simple, defensible sample sizes based on cost efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

A decision theoretic approach to sample size determination in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Study designs for dose-ranging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Crossover trials, degrees of freedom, the carryover problem and its dual

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

The Cochrane Lecture. The best and the enemy of the good: randomised controlled trials, uncertainty, and assessing the role of patient choice in medical decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Controversies concerning randomization and additivity in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Assurance in clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

Asymptotically Efficient Rank Invariant Test Procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

7 January 2021

Is the 'simple carry-over' model useful?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

7 January 2021

Cross-over trials in Statistics in Medicine: the first '25' years

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

7 January 2021

Two cheers for P-values?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

7 January 2021

Consequences of dichotomization

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

7 January 2021

Measurement in clinical trials: a neglected issue for statisticians?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

7 January 2021

Exorcising protocol-induced spirits: making the clinical trial relevant for economics

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

7 January 2021

Statistical issues in first-in-man studies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.128

7 January 2021

Identifiers

DOI

10.1038/CLPT.2010.128

1 reference

9 April 2018

1 reference

9 April 2018